Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival

Picarda, G., Lamoureux, F., Geffroy, L. et al. (7 more authors) (2010) Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival. Clinical Cancer Research, 16 (8). pp. 2363-2374. ISSN 1078-0432

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2010 AACR
Dates:
  • Published: 15 April 2010
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 19 May 2016 13:17
Last Modified: 19 May 2016 13:53
Published Version: http://dx.doi.org/10.1158/1078-0432.CCR-09-1779
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/1078-0432.CCR-09-1779
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)